| ||
Arena Diet Drug Rejection Reflects High Bar To Treat Obesity Wall Street Journal By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK (Dow Jones)--The rejection of Arena Pharmaceuticals Inc. (ARNA) and Eisai Co.'s (ESALY, 4523.TO) weight-loss drug, lorcaserin, confirms the high regulatory bar for such therapies, something that may not ... See all stories on this topic » | ||
| ||
Drinking green tea helps prevent breast cancer Food Consumer This is to add an important message to the report we released early today. While it is evident that drinking green tea may likely help prevent breast cancer and other types of malignancies, we'd like readers to know that the bottled green tea sold on ... See all stories on this topic » | ||
Study: What the Risky Sex Lives of NYC Teens Reveal TIME By Meredith Melnick Monday, October 25, 2010 | 0 comments A study of the sexual behavior of New York City high school students found that at least 9% of sexually active teens reported having had at least one same-sex partner. ... See all stories on this topic » | ||
Lungs Have Bitter Taste Receptors That May Help Treat Asthma TIME By Meredith Melnick Monday, October 25, 2010 | 0 comments Most people aren't wild about things that taste bitter, and there may be an evolutionary reason for that: bitter taste receptors on the tongue may have developed to help warn people away from ... See all stories on this topic » | ||
Novartis Submiting Meningococcal Vaccine In the US Wall Street Journal By Goran Mijuk Of DOW JONES NEWSWIRES ZURICH (Dow Jones)--Novartis AG (NVS) Monday said it will submit meningococcal disease vaccine Menveo in the US and elsewhere to treat children aged two months and older after fresh late-stage trials showed the ... See all stories on this topic » | ||
|
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment